13 January 2023
Food for Special Medical Purposes (FSMP): New specific CJEU requirements
In a decision dated 27 October 2022, the Court of Justice of the European Union (CJEU) specified the requirements for a product to be qualified as Food for Special Medical Purposes (FSMP). In its preliminary ruling (Case C-418/21), it held that it is not sufficient that the patient derives a general benefit from the intake of the product because the substances that it contains counteract the disorder or alleviate its symptoms; rather, a product constitutes an FSMP only if the disease results in increased or specific nutritional requirements which the food is intended to cover.
For more information, see here
More News
-
-
Swissmedic: New strategic Approach to minimizing Animal Testing in the Development of Medicinal Products
-
Swissmedic: The new Pharmacopoea Helvetica 13
-
European Medicines Agency: New oral GLP-1 Medicine for Weight Management and Type 2 Diabetes
-
FOPH: Capital Income of Health Insurers for Premium Reduction – current voluntary System deemed sufficient
-
Swissmedic: Haemovigilance Annual Report 2025
-
Decision C-6534/2024 of 13 October 2026
-
Swissmedic: GMP Compliance by foreign Manufacturers - Simplifications for Industry and Clarification of unresolved Issues
-
European Medicines Agency: Clinical Trial Applications Advice Pilot becomes permanent
-
Swissmedic: Revision of the Guidance document Authorisation Biosimilar